Skip to content


Some of the best and notable people from the fields of mental health, psychedelic medicine and the science driving their inevitable resurgence.

Anne Philippi

Anne Philippi is a journalist and the founder of The New Health Club, a lifestyle platform for mental wellness and the use of psychedelics. She hosts a podcast where she interviews thought leaders, innovators, and disruptors from the world of psychedelics.

Sutton King, Nāēqtaw-Pianakiw

Sutton King, MPH, Nāēqtaw-Pianakiw (comes first woman), is Afro-Indigenous and a descendent of the Menominee and Oneida Nations of Wisconsin. She is a graduate of CMSV and NYU School of Global Public Health. She holds a bachelors in Psychology, a minor in Sociology and a masters in Public Health.

Paul Stamets

Paul Stamets is an American mycologist, entrepreneur, and author. He advocates for medicinal fungi and mycoremediation. Stamets founded Fungi Perfecti, selling mushroom products, and has written books like “Mycelium Running” and “Growing Gourmet and Medicinal Mushrooms.” He promotes mushrooms’ potential in medicine, ecology, and environmental restoration.

Paul F. Austin

Paul Austin is a microdosing advocate, entrepreneur, and founder of The Third Wave, an online resource that provides information and support for individuals interested in responsible and intentional psychedelic use, including microdosing.

Andrew Gallimore

Andrew Gallimore, a neurobiologist and chemist in Tokyo, explores psychedelics as tools for interfacing with alternate realities and intelligent beings. He authored “Alien Information Theory” and the upcoming “Reality Switch Technologies,” collaborating with DMT pioneer Dr. Rick Strassman on extending the DMT state using intravenous infusion technology.

James Fadiman

James Fadiman, born May 27, 1939, is an American writer known for his research on microdosing psychedelics. He co-founded the Institute of Transpersonal Psychology, now Sofia University, and has contributed to understanding the effects of microdosing on personal growth and well-being.

Dennis McKenna

Dennis Jon McKenna, born December 17, 1950, is an American ethnopharmacologist, author, and lecturer. He is the brother of renowned psychedelics advocate Terence McKenna and serves as the director of ethnopharmacology at the Heffter Research Institute, focusing on the therapeutic applications of psychedelic medicines.

Robin Carhart-Harris

Robin Carhart-Harris, with a PhD in Psychopharmacology from the University of Bristol and an MA in Psychoanalysis from Brunel University, conducts human brain imaging studies at Imperial College London. His research focuses on the effects of LSD, psilocybin, MDMA, and DMT.

Michael Pollan

Michael Pollan is an author and journalist. In 2018, he released How to Change your Mind, which details the history of psychedelics and how they could help deal with mental health issues. The book helped normalize discussions around psychedelics in mainstream media.

Alex Grey

Alex Grey is a versatile American artist, author, teacher, and Vajrayana practitioner renowned for his spiritual and psychedelic artworks. His creative expressions span various mediums, including painting, sculpture, installation art, performance art, process art, and visionary art.

Matthew W. Johnson

Dr. Johnson is a professor of psychiatry and behavioral sciences at Johns Hopkins University School of Medicine. He has conducted extensive research on psychedelics, including psilocybin, and their therapeutic applications.

Hamilton Morris

Hamilton Morris is a journalist, filmmaker, and host of the television series “Hamilton’s Pharmacopeia.” His work often focuses on exploring and documenting the cultural, scientific, and historical aspects of various psychoactive substances, including magic mushrooms.

Dr. Roland Griffiths

The late Dr. Roland Griffiths was a professor in the departments of psychiatry and neurosciences at the Johns Hopkins University School of Medicine and founding director of the Johns Hopkins Center on Psychedelic and Consciousness Research. His work focuses primarily on the “behavioral and subjective effects of mood-altering drugs.” He has been credited with helping revive psychedelic research in the late 2000s.